Get the Stockscreener App
329.65
0.09%
0.30
After Hours:
329.65
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $329.65, with a volume of 1.25M.
It is up +0.09% in the last 24 hours and down -0.88% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$329.35
Open:
$329
24h Volume:
1.25M
Relative Volume:
0.61
Market Cap:
$126.25B
Revenue:
$25.12B
Net Income/Loss:
$3.25B
P/E Ratio:
39.25
EPS:
8.3984
Net Cash Flow:
$4.28B
1W Performance:
-2.58%
1M Performance:
-0.88%
6M Performance:
-13.94%
1Y Performance:
-7.69%
1-Day Range:
$324.90
$333.24
1-Week Range:
$324.90
$347.52
52-Week Range:
$319.32
$404.14
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
329.65 | 125.35B | 25.12B | 3.25B | 4.28B | 8.3984 |
ABT
Abbott Laboratories
|
92.48 | 161.12B | 45.13B | 6.28B | 7.40B | 3.5895 |
MDT
Medtronic Plc
|
83.79 | 105.28B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
65.69 | 88.46B | 20.62B | 3.56B | 3.66B | 2.3847 |
EW
Edwards Lifesciences Corp
|
79.72 | 45.96B | 6.07B | 1.06B | 1.34B | 1.8063 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Harbour Trust & Investment Management Co Purchases 3,160 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Shares Sold by Villere ST Denis J & Co. LLC - MarketBeat
Stryker (SYK) to Release Quarterly Earnings on Thursday - MarketBeat
Following Stryker Cyberattack, Avatier Launches Identity Challenge Card to Protect Organizations When Standard Security Fails - Yahoo! Finance Canada
Boston Trust Walden Corp Sells 6,108 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corp (SYK) Shares Fall 3.3% -- What GF Score of 93 Tells Investors - GuruFocus
Stryker Corp. stock outperforms competitors despite losses on the day - MarketWatch
Global Laparoscopy Devices Market to Register Immense Growth at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.
Stryker remains offline after cyberattack linked to Iran group - MSN
Stryker Corp. stock (US8636671013): Is medtech innovation strong enough to unlock new upside? - AD HOC NEWS
Stryker Corp. stock underperforms Monday when compared to competitors - MarketWatch
Stryker's Q1 2026 Earnings: What to Expect - Yahoo Finance
List of 55 Acquisitions by Stryker (Apr 2026) - Tracxn
Stryker Corporation (NYSE:SYK) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Stryker (NYSE:SYK) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Farther Finance Advisors LLC Boosts Stake in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Shares Sold by Campbell Newman Asset Management Inc. - MarketBeat
Cystoscopy and Ureteroscopy Market 2026 | Stryker Corp, Rudra Surgicals, Teleflex Inc, Coloplast Corp etc. - openPR.com
Stryker Hack Affects First Quarter Results - BankInfoSecurity
Stryker leads West Michigan public companies with $25.1B in revenue - Crain's Grand Rapids
Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK) - marketscreener.com
KBC Group NV Increases Position in Stryker Corporation $SYK - MarketBeat
Lbp Am Sa Has $84.59 Million Stake in Stryker Corporation $SYK - MarketBeat
Annex Advisory Services LLC Sells 15,163 Shares of Stryker Corporation $SYK - MarketBeat
General Dynamics wins $44.4M contract modification for Stryker upgrades - Investing.com
US FDA Stryker updates use instructions for patient-fitted tmj implants - marketscreener.com
Stryker Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Stryker Corp stock (US8636671013): Why its medtech leadership position matters more now for investor - AD HOC NEWS
Stryker (NYSE:SYK) Price Target Lowered to $380.00 at Truist Financial - MarketBeat
Stryker Cyberattack Has Impacted First Quarter Earnings - The HIPAA Journal
Citi Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $385 - 富途牛牛
Stryker Corp. stock (US8636671013): Is its medtech moat strong enough to unlock new upside? - AD HOC NEWS
Stryker Corp stock (US8636671013): Why its medtech leadership matters more now for long-term investo - AD HOC NEWS
Ronda Stryker (SYK) updates 15.2M-share beneficial stake and recent trades - Stock Titan
Stryker's Q1 Results to See Material Impact From March Cybersecurity Incident, RBC Says - marketscreener.com
Stryker to Acquire AVS, Adding IVL Capabilities to Vascular Portfolio - Zacks Investment Research
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $397 to $435 - 富途牛牛
Sleeping Giant acquires Walker manufacturer, taps Stryker veteran as CEO - Crain's Grand Rapids
SYK Initiated by Leerink Partners -- Rating Set to Outperform - GuruFocus
Stryker (SYK) to Acquire Amplitude Vascular Systems - GuruFocus
Stryker agrees to buy Amplitude Vascular Systems for IVL tech - BioWorld News
Stryker agrees to acquire IVL developer Amplitude Vascular Systems - Yahoo Finance
Stryker (SYK) Expands Vascular Portfolio with Amplitude Vascular Acquisition - GuruFocus
Stryker to Acquire Amplitude Vascular Systems - Medical Product Outsourcing
Stryker (NYSE:SYK) Coverage Initiated by Analysts at Leerink Partners - MarketBeat
Leerink Partners Initiates Stryker Corp(SYK.US) With Buy Rating, Announces Target Price $410 - 富途牛牛
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating - 富途牛牛
Stryker to acquire vascular device maker Amplitude Vascular By Investing.com - Investing.com Canada
Stryker to acquire vascular device maker Amplitude Vascular - Investing.com
Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio - Yahoo Finance
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.68%
2.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):